Novavax wins World Health Organization authorization of tenth emergency COVID-19 vaccine

The World Health Organization on Tuesday approved a tenth COVID-19 vaccine for emergency use.

The global health agency added Nuvaxovid, also known as NVX-CoV2373, to its emergency use listing following an approval from the European Medicines Agency (EMA).

The new vaccine was developed by Maryland-based biotech company Novavax and the ...

from The Washington Times stories: Health https://ift.tt/3J92OWp

Post a Comment

Previous Post Next Post